NRXS
What one share of Neuraxis holds
Electromedical and Electrotherapeutic Apparatus
Neuraxis’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.49 |
|---|---|
| Profit | −$0.78 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.52 |
| Cash and investments | $0.67 |
| Book value | $0.54 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $1.34 | −$2.77 | $0.00 | −$1.15 | — | −$2.84 |
| 2023 | $0.76 | −$4.50 | $0.01 | −$2.07 | — | — |
| 2024 | $0.39 | −$1.22 | $0.00 | −$0.89 | — | $0.30 |
| 2025 | $0.39 | −$0.95 | $0.00 | −$0.71 | — | $0.32 |